Viking Therapeutics: Future Weight Loss Heavyweight? [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
The company's value seems to be derived from its weight loss and NASH/MASH candidates. VK2735, the weight loss candidate, presents a potentially massively large opportunity, despite the crowded market. VK2809, the NASH/MASH candidate, now offers an attractive opportunity as a recently launched drug provides proof-of-concept for the space. Introduction Viking Therapeutics ( NASDAQ: VKTX ) is a biotech focusing on bringing metabolic treatments to market. They seem to be largely focused in areas of broad interest, such as obesity (with their GLP-1/GIP agonist), and NASH (nonalcoholic steatohepatitis, with a TR-Beta agonist). Both have had some recent excitement, for example, Eli Lilly's ( LLY ) and Novo Nordisk's ( NVO ) successes with the ever-expanding obesity market (which may surpass a hefty ~$77B within the next decade). Madrigal Pharmaceuticals' ( MDGL ) recent launch of Rezdiffra has also potentially opened up the NASH market, which may exceed ~$48B by 2035. These opportu
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Can This High-Flying Stock 10x in 10 Years? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- 11 Oversold MidCap Stocks To Buy Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.MarketBeat
- Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
VKTX
Earnings
- 4/24/24 - Beat
VKTX
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 144
- 5/2/24 - Form 4
- VKTX's page on the SEC website